, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

Sell BCR
down 49.43 %

C.r. Bard, Inc. (BCR) rated Sell by Credit Agricole

Posted on: Friday,  Feb 1, 2013  8:25 AM ET by Credit Agricole

Credit Agricole rated Sell C.r. Bard, Inc. (NYSE: BCR) on 02/01/2013, when the stock price was $99.35. Since
then, C.r. Bard, Inc. has gained 97.78% as of 01/20/2016's recent price of $196.49.
If you would have followed this Credit Agricole's recommendation on BCR, you would have lost 49.43% of your investment in 1083 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Credit Agricole
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/1/2013 8:25 AM Sell
as of 12/13/2013
1 Week up  2.79 %
1 Month up  3.18 %
3 Months down  -12.62 %
1 YTD down  -34.47 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy